Validity and Reliability of the Treatment Adherence Questionnaire for Patients with Hypertension

Natalia Esquivel Garzón, Luz Patricia Díaz Heredia

Abstract


Objective. To determine the validity and reliability of the Treatment Adherence Questionnaire for Patients with Hypertension (TAQPH), Spanish version, designed by Chunhua Ma et al.

Methods. This study was carried out in the city of Ibagué (Colombia)  and the test validation determined validity (face, content, and construct) and reliability. Face and content validity were conducted through expert judgment, using Fleiss’ Kappa Coefficient statistical tests and modified Lawshe’s content validity index. The construct validity and the reliability test had the participation of 220 people with diagnosis of primary hypertension. Reliability was calculated through Cronbach’s alpha statistical test.

Results. In the face validity, the instrument reported a Fleiss’ Kappa index was 0.68 in comprehension, 0.76 in clarity, and 0.64 in accuracy, interpreted as a substantial agreement. The content validity index was satisfactory with 0.91; el exploratory factor analysis reported six factors with a total variance explained of 54%. Cronbach’s alpha for the total scale was 0.74.

Conclusion. The Spanish version of the TAQPH is a valid and reliable scale to evaluate adherence to treatment in patients with primary hypertension.

Descriptors: essential hypertension; treatment adherence and compliance; surveys and questionnaires; psychometrics; validation studies.

How to cite this article: Esquivel N, Díaz LP. Validity and Reliability of the Treatment Adherence Questionnaire for Patients with Hypertension. Invest. Educ. Enferm. 2019; 37(3):e09.


Full Text:

PDF VIDEO

References


(1) World Health Organization. Global Status Report on Alcohol and Health 2014 [Internet]. Genève: WHO; 2014 [cited: 6 Sept 2019]. Available from: http://apps.who.int/iris/bitstream/10665/112736/1/9789240692763_eng.pdf?ua=1

(2) Organización Mundial de la Salud. Información general sobre la hipertensión en el mundo. Una enfermedad que mata en silencio, una crisis de salud pública mundial [Internet]. 2013 [cited: 6 Sep 2019]. Available from: http://apps.who.int/iris/bitstream/10665/87679/1/WHO_DCO_WHD_2013.2_spa.pdf

(3) Piette JD, Beard A, Rosland AM, McHorney CA. Beliefs that influence cost-related medication non-adherence among the “haves” and “have nots” with chronic diseases. Patient Prefer. Adherence. 2011; 5:389–96.

(4) Morrissey EC, Durand H, Nieuwlaat R, Navarro T, Haynes RB, Walsh JC, et al. Effectiveness and content analysis of interventions to enhance medication adherence and blood pressure control in hypertension: A systematic review and meta-analysis. Psychol. Heal. 2017; 32(10):1195–232.

(5) Conn VS, Ruppar TM, Chase JD, Enriquez M, Cooper PS. Interventions to Improve Medication Adherence in Hypertensive Patients: Systematic Review and Meta-analysis. Curr. Hypertens. Rep. 2015; 17(12):94.

(6) Pittman DG, Tao Z, Chen W, Stettin GD. Antihypertensive medication adherence and subsequent healthcare utilization and costs. Am. J. Manag. Care. 2010; 16(8):568–76.

(7) Vrijens B, Antoniou S, Burnier M, Sierra A De, Volpe M. Current Situation of Medication Adherence in Hypertension. Front. Pharmacol. 2017; 8:10.

(8) Jimmy B, Jose J. Patient Medication Adherence: Measures in Daily Practice. Oman Med. J. 2011; 26(3):155–9.

(9) Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive Validity of A Medication Adherence Measure in an Outpatient Setting. J. Clin. Hypertens. (Greenwich). 2008; 10(5):348–54.

(10) Svarstad BL, Chewning BA, Sleath BL, Claesson C. The brief medication questionnaire: A tool for screening patient adherence and barriers to adherence. Patient Educ. Couns. 1999; 37(2):113–24.

(11) Kim M, Hill M, Bone L, Levine D. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog. Cardiovasc. Nurs. 2000; 15(3):90–6.

(12) Martin L, Bayarre H, Grau J. Validation of MBG Questionnaire (Martin-Bayarre-Grau) for the evaluation of therapy adherence in blood hypertension patients. Rev. Cubana Salud Pública [Internet]. 2008 [cited: 6 Sep 2019]; 24(1). Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662008000100012&lng=es.

(13) Wetzels G, Nelemans P, Wijk van B, Broers N, Schouten J, Prins M. Determinants of poor adherence in hypertensive patients: Development and validation of the ‘“Maastricht Utrecht Adherence in Hypertension (MUAH)-questionnaire.”’ Patient Educ. Couns. 2006; 64:151–8.

(14) Lahdenperä TS, Wright CC, Kyngäs HA. Development of a scale to assess the compliance of hypertensive patients. Int. J. Nurs. Stud. 2003; 40(7):677–84.

(15) World Health Organization. Adherence to Long-Term Therapies. Evidence for action. [Internet]. 1st ed. WHO, editor. Geneva, Switzerland: World Health Organization; 2003 [cited: 6 Sep 2019]. Available from: http://apps.who.int/medicinedocs/pdf/s4883e/s4883e.pdf

(16) Ma C, Chen S, You L, Luo Z, Xing C. Development and psychometric evaluation of the Treatment Adherence Questionnaire for Patients with Hypertension. J. Adv. Nurs. 2012; 68(6):1402–13.

(17) Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977; 33(1):159–74.

(18) Tristán-López A. Modificación al modelo de Lawshe para el dictamen cuantitativo de la validez de contenido de un instrumento objetivo. Av. Medición. 2003; 6(1):37–48.

(19) Gorsuch RL. Factor analysis. 2nd Ed. Hillsdale, New Jersey: Lawrence Erlbaum; 1983.

(20) Bandalos DL, Finney SJ. Factor Analysis: Exploratory and Confirmatory. In: Hancock GR, Mueller RO, editors. Reviewer’s Guide to Quantitative Methods. Routledge: New York; 2010. P. 449.

(21) Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int. J. Med. Educ. 2011; 2:53–5.

(22) Streiner DL. Starting at the Beginning: An Introduction to Coefficient Alpha and Internal Consistency. J. Pers. Assess. 2003; 80(1):99–103.

(23) Dehghan M, Dehghan-Nayeri N, Iranmanesh S. Translation and validation of the Persian version of the treatment adherence questionnaire for patients with hypertension. ARYA Atheroscler. 2016;12(2):76-86.




DOI: https://doi.org/10.17533/udea.iee.v37n3e09 Abstract : 66 PDF : 43 VIDEO : 3

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Esta publicación hace parte del Sistema de Revistas de la Universidad de Antioquia
¿Quieres aprender a usar el Open Journal system? Ingresa al Curso virtual
Este sistema es administrado por el Programa Integración de Tecnologías a la Docencia
Universidad de Antioquia
Powered by Public Knowledge Project